BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 21979058)

  • 1. Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall.
    Ketelhuth DF; Hansson GK
    Thromb Haemost; 2011 Nov; 106(5):779-86. PubMed ID: 21979058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
    van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells in atherosclerosis: functions in immune regulation and beyond.
    Manthey HD; Zernecke A
    Thromb Haemost; 2011 Nov; 106(5):772-8. PubMed ID: 21901235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Response of T and B Cells in Atherosclerosis.
    Ketelhuth DF; Hansson GK
    Circ Res; 2016 Feb; 118(4):668-78. PubMed ID: 26892965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive T cell immune responses and atherogenesis.
    Taleb S; Tedgui A; Mallat Z
    Curr Opin Pharmacol; 2010 Apr; 10(2):197-202. PubMed ID: 20207195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
    Nilsson J; Wigren M; Shah PK
    Trends Cardiovasc Med; 2009 Nov; 19(8):272-6. PubMed ID: 20447570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis.
    Kyriakakis E; Cavallari M; Andert J; Philippova M; Koella C; Bochkov V; Erne P; Wilson SB; Mori L; Biedermann BC; Resink TJ; De Libero G
    Eur J Immunol; 2010 Nov; 40(11):3268-79. PubMed ID: 21061446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination strategies in atherosclerosis.
    de Jager SC; Kuiper J
    Thromb Haemost; 2011 Nov; 106(5):796-803. PubMed ID: 22012002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models.
    Weber C; Zernecke A; Libby P
    Nat Rev Immunol; 2008 Oct; 8(10):802-15. PubMed ID: 18825131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
    Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
    J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytes in atherosclerosis.
    Wigren M; Nilsson J; Kolbus D
    Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice.
    Xie JJ; Wang J; Tang TT; Chen J; Gao XL; Yuan J; Zhou ZH; Liao MY; Yao R; Yu X; Wang D; Cheng Y; Liao YH; Cheng X
    Cytokine; 2010 Feb; 49(2):185-93. PubMed ID: 19836260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies.
    Whitman SC; Ramsamy TA
    Can J Physiol Pharmacol; 2006 Jan; 84(1):67-75. PubMed ID: 16845892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-tailored therapy based on the inflammatory theory of atherosclerosis.
    Harats D; George J
    Expert Rev Vaccines; 2004 Oct; 3(5):605-11. PubMed ID: 15485340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.
    Wolfs IM; Donners MM; de Winther MP
    Thromb Haemost; 2011 Nov; 106(5):763-71. PubMed ID: 21947328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells in atherogenesis: for better or for worse?
    Robertson AK; Hansson GK
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2421-32. PubMed ID: 16973967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages and T cells in atherosclerosis: a translational perspective.
    Bartlett B; Ludewick HP; Misra A; Lee S; Dwivedi G
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H375-H386. PubMed ID: 31199186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.